Detalles de la búsqueda
1.
Sexually transmitted and blood-borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: Findings from a Canadian pragmatic randomized trial.
HIV Med
; 2024 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38506171
2.
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study.
Pharmacopsychiatry
; 57(3): 141-151, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38467156
3.
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder in Canada.
Am J Addict
; 2024 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38877969
4.
Associations Between Buprenorphine\Naloxone and Methadone Treatment and non-Opioid Substance Use in Prescription-Type Opioid Use Disorder: Secondary Analyses From the OPTIMA Study: Associations entre le traitement avec la buprénorphine/naloxone et avec la méthadone et l'utilisation de substances non opioïdes dans le trouble lié à l'usage d'opioïdes de type sur ordonnance : analyses secondaires de l'étude OPTIMA.
Can J Psychiatry
; 69(4): 252-263, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37899716
5.
The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial.
Can J Psychiatry
; 69(3): 172-182, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37697811
6.
Computer-Based Training for Cognitive Behavioural Therapy for Substance Use Disorder: A Randomized Controlled Trial Including Quantitative and Qualitative Health and Economic Outcomes: Formation informatisée pour la thérapie cognitivo-comportementale pour les troubles liés à l'usage de substances : un essai randomisé contrôlé y compris les résultats quantitatifs et qualitatifs en matière de santé et d'économie.
Can J Psychiatry
; : 7067437241255100, 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38783836
7.
Participant Fraud in Virtual Qualitative Substance Use Research: Recommendations and Considerations for Detection and Prevention Based on a Case Study.
Subst Use Misuse
; 59(8): 1261-1270, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38503716
8.
Cannabis Use Characteristics Associated with Self-Reported Cognitive Function in a Nationally Representative U.S. sample.
Subst Use Misuse
; 59(9): 1303-1312, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38664196
9.
Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial.
J Dual Diagn
; : 1-12, 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38580298
10.
Effectiveness of Bupropion and Varenicline for Smokers With Baseline Depressive Symptoms.
Nicotine Tob Res
; 25(5): 937-944, 2023 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36520964
11.
Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada.
Qual Life Res
; 32(8): 2209-2221, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37027087
12.
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey.
Am J Addict
; 32(5): 497-505, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37329255
13.
Marked Increase in Amphetamine-Related Emergency Department Visits and Inpatient Admissions in Toronto, Canada, 2014-2021.
Can J Psychiatry
; 68(4): 249-256, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36809914
14.
Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study.
Am J Addict
; 32(5): 469-478, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37308805
15.
Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial.
Can J Psychiatry
; 68(8): 572-585, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36519188
16.
Evaluating Back-to-Back and Day-to-Day Reproducibility of Cortical GABA+ Measurements Using Proton Magnetic Resonance Spectroscopy (1H MRS).
Int J Mol Sci
; 24(9)2023 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37175420
17.
The Effect of Nicotine Dependence on the Risk of Developing Post-traumatic Stress Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions.
Nicotine Tob Res
; 24(5): 719-727, 2022 03 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34734244
18.
3-Year Follow-up of Lower Risk Cannabis Use Patterns: Evidence from a Longitudinal Survey.
Can J Psychiatry
; 67(1): 48-56, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33657893
19.
Comparing immediate- and delayed-onset posttraumatic stress disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III).
J Trauma Stress
; 35(6): 1744-1755, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36106343
20.
Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review.
Harm Reduct J
; 19(1): 113, 2022 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36229831